Navigation Links
Spanish Drug Companies Have New Support Option for the U.S. Market
Date:7/19/2011

BARCELONA, Spain, July 19, 2011 /PRNewswire/ -- Spanish drug companies face a number of obstacles to commercialize products or technologies in the United States.  From regulatory (FDA) and GMP compliance, to distribution agreements and the search for project funding, there are many areas that must be coordinated.  Those issues have just become easier to manage as Spanish company KIM and U.S. company VPCI have entered into a joint association.  The collaboration will provide Spanish pharmaceutical, biotechnology and medical device companies the necessary support for compliance and commercialization of their products or know-how in the U.S. market.

(Logo: http://photos.prnewswire.com/prnh/20110719/DE35430LOGO)

"This collaboration will provide a unique set of benefits," said Franco DeVecchi, Jr., Vice President of VPCI.  "A Spanish pharmaceutical or medical device company looking to enter the U.S. market can now focus on a single point of contact for support.  Our association with KIM allows for local guidance from a project's conception all the way through commercialization in the U.S.  The services of our group have now been greatly expanded and our clients will see immediate benefits."

The agreements were signed in Washington D.C. during the BIO Washington 2011 conference in which KIM participated jointly with the Catalan delegation led by Biocat.  The convention is one of the largest in the international biotechnology sector.  KIM's Healthcare Director, Marti Dalmases said, "We are happy to expand our network of partners.  This new agreement is definitely going to help with the arrival in the U.S. of technologies developed in Spain."

About VPCI

VPCI, Inc. (Vectech Pharmaceutical Consultants International) (www.vpcint.com) is a Pharmaceutical consulting company in the U.S. which offers FDA regulatory guidance, manufacturing technology support and high-level business development services.  With scientific and technical experts on a global scale, VPCI has the ability to communicate with clients and regulatory agencies in a number of languages, strictly following good manufacturing practices (GMP).

About KIM

KIM is a service organization located in Barcelona that was formed to improve its clients' competitiveness and technological progress by offering them specialized services and executing projects related to innovation and transfer of technology and knowledge.  KIM's services include, but are not limited to, project assessment, valuation, commercialization and innovation.

Contact:
VPCI, Inc. (USA)
Franco DeVecchi, Jr., Vice President
Phone:  +1 (248) 538-5150
www.vpcint.com
info@vpcint.com

KIM (Spain)
Marti Dalmases, Healthcare Director
Phone:  +34 (93) 266 71 38
www.kimbcn.org
mdalmases@kimglobal.com


'/>"/>
SOURCE VPCI, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
2. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
3. Pharmaceutical Companies Lead Fight Against Staph and Other Infectious Diseases
4. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
5. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
6. Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743
7. R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges
8. BIOCOMs 4th Annual DeviceFest Honors Companies
9. invivodata Recognized as One of Pittsburghs Fastest Growing Private Companies
10. Announcing Companies to Present at the 7th Annual MidAmerica Healthcare Venture Forum
11. Facilitation Payments Seen as Problematic by Many Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , May 25,2016 ... the near-infrared Cellvizio platform for urological and surgical ... OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal ... regulatory milestone in the US with the 12 ... and Drug Administration (FDA). This new FDA clearance ...
(Date:5/25/2016)... India , May 25, 2016 ... Animation Market by Type (3D, 2D, 4D), by Therapeutic ... Education), by End User (Medical Device Manufacturers, Hospitals/ Clinics) ... studies the global Medical Animation Market for the forecast ... to reach USD 301.3 Million by 2021 from USD ...
(Date:5/25/2016)... GERMANTOWN, Maryland , May 25, 2016 /PRNewswire/ ... dringenden Bedarf zur Steuerung ... N.V. (NASDAQ: QGEN ; Frankfurt Prime ... Entwicklungsvereinbarung mit Therawis Diagnostics GmbH zur Entwicklung und ... sein. Ein erstes Projekt wird die Entwicklung und ...
Breaking Medicine Technology:
(Date:5/25/2016)... San Francisco, CA (PRWEB) , ... May 26, 2016 , ... ... 1st, 2016, from 6pm to 7.30pm PST at HP in Palo Alto, CA. This ... panel discussion will be led by clinical trial experts from the pharmaceutical company Hallux, ...
(Date:5/25/2016)... ... May 25, 2016 , ... “We are ... Partner at HealthScape Advisors. “Brad brings significant experience advising healthcare provider clients throughout ... accelerates with the implementation of MACRA, we believe that continuing to add professionals ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... The Georgia ... Award of Excellence from the Atlanta Urban Design Commission. , The annual award recognizes ... city of Atlanta’s built environment, the preservation of its physical heritage and the balance ...
(Date:5/25/2016)... ... 2016 , ... Serenity Recovery, a holistic treatment center for ... the many supplemental program options offered at their rehabilitation facility, this time focusing ... Belt in the Shorin-ryu style of Karate that originated in Okinawa, Japan, and ...
(Date:5/25/2016)... ... ... to an article published May 5th on The Daily Mail, a survey pointed ... it found that more than a third cited unappealing breath a one of their top ... a failure to brush after meals, can typically be attributed to gum disease. Moreover, the ...
Breaking Medicine News(10 mins):